tirzepatide for ckd 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction ( A Study of Tirzepatide (LY3298176)
Description
Ozempic has been FDA-approved for type 2 diabetes, while Wegovy (its higher-dose version) is approved for chronic weight management
No clinic visits
During this mid-phase window, you may also notice non-scale victories that matter just as much as pounds lost
Shaking the vial vigorously This is perhaps the most widespread mistake
van Hout B, Janssen MF, Feng Y-S, et al
2011;300:E103846
